Pozescaf
New York, New York, United States
PozeSCAF is a preclinical drug discovery Contract Research Organization (CRO) that focuses on leveraging an in-house generative AI-based discovery platform called AxDrug, integrated with various computational and synthetic chemistry tools. The company aims to create leading candidates for clients in drug discovery through advanced methodologies such as virtual screening, hit identification, lead optimization, and medicinal chemistry synthesis. Their robust offerings include extensive screening protocols, predictive modeling for protein structures, and a comprehensive database containing over 20 billion drug-like small molecules. PozeSCAF stands out for its innovative use of AI and computational methods, significantly enhancing the drug development process and reducing R&D costs for clients.
Company Info
- Founded
- 2017
- Website
- pozescaf.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Pozescaf?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.